業績

HOME＞業績＞２０１０年以前の研究業績
２０１８年度研究業績
２０１７年度研究業績
２０１６年度研究業績
２０１５年度研究業績
２０１４年度研究業績
２０１３年度研究業績
２０１２年度研究業績
２０１１年度研究業績
２０１０年度研究業績
  1. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, et al. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest. 2010;90(11):1637-44.
  2. Satoh K, Kawakami A, Shirabe S, Tamai M, Sato A, Tsujihata M, et al. Anti-cyclic citrullinated peptide antibody (anti-CCP antibody) is present in the sera of patients with dementia of Alzheimer's type in Asian. Acta Neurol Scand. 2010;121(5):338-41.
  3. Nakamura H, Okada A, Kawakami A, Yamasaki S, Ida H, Masuda T, et al. Rheumatoid vasculitis of crural muscles confirmed by muscle biopsy in the absence of inflammatory myopathy: histologic and MRI study. Rheumatol Int. 2010;30(10):1381-3.
  4. Matsui Y, Satoh K, Mutsukura K, Watanabe T, Nishida N, Matsuda H, et al. Development of an ultra-rapid diagnostic method based on heart-type fatty acid binding protein levels in the CSF of CJD patients. Cell Mol Neurobiol. 2010;30(7):991-9.
  5. Mutsukura K, Satoh K, Shirabe S, Tomita I, Fukutome T, Morikawa M, et al. Familial Creutzfeldt-Jakob disease with a V180I mutation: comparative analysis with pathological findings and diffusion-weighted images. Dement Geriatr Cogn Disord. 2009;28(6):550-7.
  6. Ida H, Aramaki T, Nakamura H, Fujikawa K, Arima K, Tamai M, et al. Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis. Cytotechnology. 2009;60(1-3):161-4.
  7. Takakura Y, Yamaguchi N, Nakagaki T, Satoh K, Kira J, Nishida N. Bone marrow stroma cells are susceptible to prion infection. Biochem Biophys Res Commun. 2008;377(3):957-61.
  8. Shiga Y, Satoh K, Kitamoto T, Kanno S, Nakashima I, Sato S, et al. Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol. 2007;254(11):1509-17.
  9. Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 2007;24(3):207-12.
  10. Satoh K, Shirabe S, Eguchi K. [Clinical typing and diagnosis of sporadic human prion diseases (classic sproadic CJD, MM2-cortical form CJD, MM2-thalamic form CJD)]. Nihon Rinsho. 2007;65(8):1423-32.
  11. Satoh K, Shirabe S, Eguchi H, Tsujino A, Motomura M, Satoh A, et al. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients. Dement Geriatr Cogn Disord. 2007;23(6):372-81.
  12. Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol. 2006;26(1):45-52.
  13. Tanaka T, Kinoshita I, Saitoh Y, Satoh K, Nishiura Y, Shirabe S, et al. [A case of Creutzfeldt-Jakob disease with a point mutation of prion protein at codon 180]. No To Shinkei. 2004;56(12):1025-8.
  14. Satoh K, Muramoto T, Tanaka T, Kitamoto N, Ironside JW, Nagashima K, et al. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases. J Gen Virol. 2003;84(Pt 10):2885-93.
  15. Satoh K, Motomura M, Suzu H, Nakao Y, Fujimoto T, Fukuda T, et al. Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. J Neurol Sci. 2001;183(1):1-4.